Katherine Leah Wisner Feinberg School of Medicine, Feinberg Clinical, Psychiatry and Behavioral Sciences

Katherine Leah Wisner

    Feinberg School of Medicine
    Feinberg Clinical
    Psychiatry and Behavioral Sciences
    Current Appointments:

    Professor; Psychiatry and Behavioral Sciences; Feinberg School of Medicine

    Professor; Obstetrics and Gynecology; Feinberg School of Medicine

    Norman and Helen Asher Professor of Psychiatry and Behavioral Sciences; Faculty Affairs; Feinberg School of Medicine

Research Interest Keywords

Depression, Pharmacology, Psychiatry, Women's Health, Women's Health; Women's Reproductive Health

Office phone



Scopus Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.

Does fetal exposure to SSRIs or maternal depression impact infant growth?

Katherine L. Wisner; Debra L. Bogen; Dorothy Sit; Mary McShea; Carolyn Hughes; David Rizzo; Andrea Confer; James Luther; Heather Eng; Stephen W. Wisniewski

(Profiled Author: Katherine Leah Wisner)

American Journal of Psychiatry. 2013;170(5):485-493.


Objective: The aim of this study was to compare the growth of infants born to women with antenatal major depressive disorder, either untreated or treated with selective serotonin reuptake inhibitor (SSRI) antidepressants, and infants born to a nondepressed, nonmedicated comparison group across the first year of life. Method: In this prospective observational study, pregnant women were evaluated at weeks 20, 30, and 36 of gestation, and mother and infant pairs were assessed at 2, 12, 26, and 52 weeks postpartum. Three nonoverlapping groups of women were defined according to their pregnancy exposures: 1) no SSRI and no depression (N=97), 2) SSRI (N=46), and 3) major depression without SSRI (N=31). Maternal demographic and clinical characteristics and newborn outcomes were compared across exposure groups. Infant weight, length, and head circumference were measured by a physician or physician's assistant who was blind to depression and SSRI exposure status at each postpartum time point. Results: Both adjusted and unadjusted analyses revealed neither antenatal major depression nor SSRI exposure was significantly associated with infant weight, length, or head circumference relative to nonexposure to either. In addition, the interaction of group and prepregnancy body mass index was also evaluated, and no significant synergistic effect was identified. Similarly, no differential effect of group over time was observed for weight, length, or head circumference. Conclusions: In utero exposure to major depression or SSRI antidepressants did not affect infant growth with respect to weight, length, or head circumference from birth through 12 months of age.

PMID: 23511234     PMCID: PMC4113116    

Scientific Context

This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.

Related Publications

Related Topics

Appears in this Publication Appears in this Document

Related Experts

Author of this Publication Author of this Document